Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
Pharmacotherapy in coronary artery disease (2)
